Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.
Treeline Biosciences has raised $200.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Treeline Biosciences's investors include OrbiMed, ARCH Venture Partners, Fidelity, Kohlberg Kravis Roberts, GV.
Treeline Biosciences is headquartered in Watertown, United States.
Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.
Treeline Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Treeline Biosciences — Funding & Investors." VCBacked, September 3, 2025, https://www.vcbacked.co/company/treeline-biosciences. Accessed July 19, 2026.
VCBacked. (2025). Treeline Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/treeline-biosciences
{{cite web |title=Treeline Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/treeline-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated